Status:
COMPLETED
Adolescents Living With HIV (ALWH): Social Networks, Adherence and Retention
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
HIV/AIDS
Eligibility:
All Genders
15-21 years
Phase:
NA
Brief Summary
human immunodeficiency virus / acquired immunodeficiency syndrome (HIV/AIDS) is the second leading cause of death in Africa. Adolescents living with HIV (ALWH) are at increased risk for HIV-related mo...
Detailed Description
This K08 focuses on the preparation phase, which consists of compiling information from various sources, including behavioral theory, scientific literature, secondary analyses of existing data, and fo...
Eligibility Criteria
Inclusion
- reside in study area
- able to provide consent or assent
- agreeable to allowing the research team to have access to their clinic data to assess retention in human immunodeficiency virus- (HIV) care and antiretroviral therapy (ART) adherence
- each Adolescents living with HIV (ALWH) must recruit at least one social network member to participate in the intervention with them
Exclusion
- None
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04077047
Start Date
September 1 2022
End Date
July 31 2025
Last Update
January 2 2026
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University School of Medicine
Winston-Salem, North Carolina, United States, 27101
2
Desmond Tutu Health Foundation
Cape Town, South Africa